MDS Nordion is a global health science company that provides market-leading products and services used for the prevention, diagnosis and treatment of disease. We are a leading provider of innovative technologies for use in medical imaging and radiotherapeutics, and sterilization technologies benefiting the lives of millions of people in more than 65 countries around the world. Our products and services are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Learn more >
Customers use our gamma sterilization technologies to sterilize medical surgical supplies and devices, as well as certain consumer products, such as food and cosmetics.
MDS Nordion produces a comprehensive range of products for medical imaging used to diagnose heart disease and various forms of cancer. We also supply targeted therapies for a variety of cancers.
Stock Price
Sep 8 4:00 p.m.
ET
Delayed 20 minutes
TSX:MDS
PRICE: $
CHANGE:
VOLUME:188,000
NYSE:MDZ
PRICE: $
CHANGE:
VOLUME:156,600
Latest News
Sep. 3: MDS Nordion Appoints Kenneth Newport to its Board of Directors
Sep. 3: MDS to Release Third Quarter 2010 Financial Results (Webcast)
Upcoming Events
Oct. 2 - 6: CIRSE – Cardiovascular and Interventional Radiological Society of Europe
